Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats

Conclusions: By reducing oxidative stress, inflammation, and apoptosis, IMD may represent a promising novel therapeutic target mitigating diabetic ischemic heart injury.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Source Type: research